GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 184 filers reported holding GW PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $13,618,000 | -0.9% | 79,000 | -3.1% | 2.68% | -4.2% |
Q1 2019 | $13,738,000 | +174.2% | 81,500 | +181.0% | 2.79% | +210.8% |
Q3 2018 | $5,010,000 | +22.4% | 29,000 | -6.5% | 0.90% | -43.2% |
Q4 2017 | $4,092,000 | +24.1% | 31,000 | -4.6% | 1.58% | +67.1% |
Q3 2017 | $3,298,000 | +49.6% | 32,500 | +47.7% | 0.95% | +22.7% |
Q2 2017 | $2,205,000 | -39.2% | 22,000 | -26.7% | 0.77% | -56.6% |
Q1 2017 | $3,629,000 | -32.3% | 30,000 | -37.5% | 1.78% | -44.4% |
Q4 2016 | $5,364,000 | -17.5% | 47,998 | -2.0% | 3.19% | +20.3% |
Q3 2016 | $6,504,000 | +317.7% | 49,000 | +188.2% | 2.66% | +298.2% |
Q2 2016 | $1,557,000 | – | 17,000 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|